{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:15:03Z","timestamp":1784556903495,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012332","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T00:00:00Z","timestamp":1490572800000}}],"reference-count":115,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012332.pub2","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T03:33:33Z","timestamp":1490672013000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Oral nonsteroidal anti-inflammatory drugs for fibromyalgia in adults"],"prefix":"10.1002","volume":"2020","author":[{"given":"Sheena","family":"Derry","sequence":"first","affiliation":[{"name":"Oxford Oxfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"H\u00e4user","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen; Department of Psychosomatic Medicine and Psychotherapy; Langerstr. 3 M\u00fcnchen Germany D-81675"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"M\u00fccke","sequence":"additional","affiliation":[{"name":"University Hospital of Bonn; Department of Palliative Medicine; Sigmund-Freud-Str. 25 Bonn Germany 53127"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Rudolf","family":"T\u00f6lle","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen; Department of Neurology, Klinikum Rechts der Isar; M\u00f6hlstrasse 28 Munich Germany 81675"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae Frances","family":"Bell","sequence":"additional","affiliation":[{"name":"Haukeland University Hospital; Regional Centre of Excellence in Palliative Care; Bergen Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD012332.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/art.1780291110","article-title":"A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia","volume":"29","author":"Goldenberg","year":"1986","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J094v02n01_02","article-title":"Alprazolam and ibuprofen in the treatment of fibromyalgia-report of a double-blind placebo-controlled study","volume":"2","author":"Kravitz","year":"1994","journal-title":"Journal of Musculoskeletal Pain"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ijcp.12760","article-title":"A randomised, double-blinded study comparing giving etoricoxib vs. placebo to female patients with fibromyalgia","volume":"70","author":"Mahagna","year":"2016","journal-title":"International Journal of Clinical Practice"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0304-3959(95)00199-9","article-title":"Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial","volume":"65","author":"Quijada-Carrera","year":"1996","journal-title":"Pain"},{"issue":"5","key":"10.1002\/14651858.CD012332.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/art.1780340507","article-title":"Treatment of primary fibrositis\/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study","volume":"34","author":"Russell","year":"1991","journal-title":"Arthritis & Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD012332.pub2-BIB0006|cit6","first-page":"527","article-title":"Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial","volume":"16","author":"Yunus","year":"1989","journal-title":"Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD012332.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/030006058000800602","article-title":"A comparative double-blind study of tiaprofenic acid and aspirin in the treatment of muscular rheumatism, fibrositis, sprains and soft tissue injuries in general practice","volume":"8","author":"Donald","year":"1980","journal-title":"Journal of International Medical Research"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0008|cit8","first-page":"99","article-title":"Combined therapy with cyclobenzaprine and ibuprofen in primary fibromyalgia syndrome","volume":"12","author":"Fossaluzza","year":"1992","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"10","key":"10.1002\/14651858.CD012332.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1185\/03007998809111116","article-title":"A double-blind comparison of ibuprofen, placebo and ibuprofen with meptazinol in soft tissue rheumatism","volume":"10","author":"Gallez","year":"1988","journal-title":"Current Medical Research and Opinion"},{"issue":"5","key":"10.1002\/14651858.CD012332.pub2-BIB0010|cit10","first-page":"301","article-title":"Tenoxicam in soft-tissue rheumatism","volume":"69","author":"Schorn","year":"1986","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.37842","article-title":"The fibromyalgia family study: a genome-wide linkage scan study","volume":"65","author":"Arnold","year":"2013","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2474-8-27","article-title":"An internet survey of 2,596 people with fibromyalgia","volume":"8","author":"Bennett","year":"2007","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.3899\/jrheum.081090","article-title":"Minimal clinically important difference in the fibromyalgia impact questionnaire","volume":"36","author":"Bennett","year":"2009","journal-title":"Journal of Rheumatology"},{"issue":"9894","key":"10.1002\/14651858.CD012332.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Bhala","year":"2014","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.amjmed.2009.09.008","article-title":"Pathophysiology of fibromyalgia","volume":"122 (12 Suppl)","author":"Bradley","year":"2009","journal-title":"American Journal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012332.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jpain.2010.01.267","article-title":"The association between incident self-reported fibromyalgia and nonpsychiatric factors: 25-years follow-up of the Adventist Health Study","volume":"11","author":"Choi","year":"2010","journal-title":"Journal of Pain"},{"issue":"15","key":"10.1002\/14651858.CD012332.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0019|cit19","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/rheumatology\/keu332","article-title":"Inadequate pain relief and large functional loss among patients with knee osteoarthritis: evidence from a prospective multinational longitudinal study of osteoarthritis real-world therapies","volume":"54","author":"Conaghan","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"f2304","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD012332.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00482-012-1167-z","article-title":"Fibromyalgia syndrome. General principles and coordination of clinical care and patient education","volume":"26","author":"Eich","year":"2012","journal-title":"Schmerz"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0025|cit25","unstructured":"European Medicines Agency EMEA public statement on the suspension of the marketing authorisation for Bextra (valdecoxib) in the European Union ema.europa.eu\/docs\/en_GB\/document_library\/Public_statement\/2009\/12\/WC500018391.pdf (accessed 23 August 2016) 2005"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0026|cit26","unstructured":"Effective Practice Organisation of Care (EPOC) EPOC worksheets for preparing a Summary of Findings (SoF) table using GRADE. Resources for review authors Oslo: Norwegian Knowledge Centre for the Health Services 2015"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11136-013-0443-4","article-title":"Don't middle your MIDs: regression to the mean shrinks estimates of minimally important differences","volume":"23","author":"Fayers","year":"2014","journal-title":"Quality Life Research"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0028|cit28","unstructured":"Food Drug Administration FDA Public Health Advisory: safety of Vioxx www.fda.gov\/drugs\/drugSafety\/postmarketdrugsafetyinformationforpatientsandproviders\/ucm106274.htm (accessed 23 August 2016) 2004"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1155\/2013\/918216","article-title":"2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summary","volume":"18","author":"Fitzcharles","year":"2013","journal-title":"Pain Research Management"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0030|cit30","first-page":"2458","article-title":"Prognostic factors for the development of fibromyalgia in women with self-reported musculoskeletal pain. A prospective study","volume":"26","author":"Forseth","year":"1999","journal-title":"Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD012332.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.psyneuen.2011.07.021","article-title":"Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia","volume":"37","author":"Geiss","year":"2012","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"10.1002\/14651858.CD012332.pub2-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010585","article-title":"Combination pharmacotherapy for the treatment of fibromyalgia","author":"Gilron","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD012332.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence--inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Cinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012332.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.neuroscience.2006.11.029","article-title":"Further characterization of a rat model of varicella zoster virus-associated pain: relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic\u00a0drugs","volume":"144","author":"Hasnie","year":"2007","journal-title":"Neuroscience"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0038|cit38","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ejpain.2009.01.006","article-title":"Guidelines on the management of fibromyalgia syndrome - a systematic review","volume":"14","author":"H\u00e4user","year":"2010","journal-title":"European Journal of Pain"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/acr.20328","article-title":"Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis","volume":"63","author":"H\u00e4user","year":"2011","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1471-2474-13-74","article-title":"The German fibromyalgia consumer reports - a cross-sectional survey","volume":"13","author":"H\u00e4user","year":"2012","journal-title":"BMC Musculoskeletal Disorders"},{"issue":"8","key":"10.1002\/14651858.CD012332.pub2-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.pain.2013.03.034","article-title":"Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome","volume":"154","author":"H\u00e4user","year":"2013","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010292","article-title":"Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome","author":"H\u00e4user","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD012332.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/j.1532-2149.2014.00453.x","article-title":"Fibromyalgia syndrome - a somatoform disorder?","volume":"18","author":"H\u00e4user","year":"2014","journal-title":"European Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/ar4441","article-title":"Review of pharmacological therapies in fibromyalgia syndrome","volume":"16","author":"H\u00e4user","year":"2014","journal-title":"Arthritis Research and Therapy"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"13","author":"H\u00e4user","year":"2015","journal-title":"Nature Reviews Disease Primers"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"1-2","key":"10.1002\/14651858.CD012332.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jneuroim.2011.10.013","article-title":"Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels","volume":"242","author":"Kadetoff","year":"2012","journal-title":"Journal of Neuroimmunology"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0736-0266(01)00114-0","article-title":"Epidural injection of cyclooxygenase-2 inhibitor attenuates pain-related behavior following application of nucleus pulposus to the nerve root in the rat","volume":"20","author":"Kawakami","year":"2002","journal-title":"Journal of Orthopaedic Research"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2377-11-55","article-title":"Fibromyalgia and neuropathic pain - differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia","volume":"11","author":"Koroschetz","year":"2011","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1053\/gast.2001.21907","article-title":"Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient","volume":"120","author":"Laine","year":"2001","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1002\/14651858.CD012332.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00482-010-0937-8","article-title":"Influence of depression on fibromyalgia: a systematic review","volume":"24","author":"Lange","year":"2010","journal-title":"Schmerz"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00296-010-1678-9","article-title":"Candidate gene studies of fibromyalgia: a systematic review and meta-analysis","volume":"32","author":"Lee","year":"2012","journal-title":"Rheumatology International"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD012332.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2125.2010.03627.x","article-title":"Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community","volume":"69","author":"Mangoni","year":"2010","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/j.pain.0000000000000314","article-title":"A systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population","volume":"157","author":"Mansfield","year":"2016","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0061|cit61","volume-title":"An Evidence-based Resource for Pain Relief","author":"McQuay","year":"1998"},{"issue":"10","key":"10.1002\/14651858.CD012332.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3899\/jrheum.090367","article-title":"Fibromyalgia syndrome module at OMERACT 9: domain construct","volume":"36","author":"Mease","year":"2009","journal-title":"Journal of Rheumatology"},{"issue":"Pt A","key":"10.1002\/14651858.CD012332.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.cct.2015.07.019","article-title":"Are current standards of reporting quality for clinical trials sufficient in addressing important sources of bias?","volume":"45","author":"Mills","year":"2015","journal-title":"Contemporary Clinical Trials"},{"issue":"7","key":"10.1002\/14651858.CD012332.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0066|cit66","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012332.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD012332.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"12","key":"10.1002\/14651858.CD012332.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub2","article-title":"Amitriptyline for neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1002\/14651858.CD012332.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"4","key":"10.1002\/14651858.CD012332.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/papr.12100","article-title":"Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"8","key":"10.1002\/14651858.CD012332.pub2-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000088","article-title":"Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting","volume":"156","author":"Moore","year":"2015","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/acr.20118","article-title":"Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norwegian Nord-Tr\u00f8ndelag Health Study","volume":"62","author":"Mork","year":"2010","journal-title":"Arthritis Care & Research"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0084|cit84","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/art.33346","article-title":"Sleep problems and risk of fibromyalgia: longitudinal data on an adult female population in Norway","volume":"64","author":"Mork","year":"2012","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD012332.pub2-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1136\/annrheumdis-2011-201249","article-title":"Comparative efficacy of pharmacological and non-pharmacological interventions in fibromyalgia syndrome: network meta-analysis","volume":"72","author":"N\u00fcesch","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685.x","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012332.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","article-title":"Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia","volume":"154","author":"Oaklander","year":"2013","journal-title":"Pain"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0088|cit88","unstructured":"Pain Palliative and Supportive Care Group PaPaS author and referee guidance papas.cochrane.org\/papas-documents (accessed 23 August 2016)"},{"issue":"10","key":"10.1002\/14651858.CD012332.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.sjpain.2016.07.002","article-title":"Osteoarthritis patients with pain improvement are highly likely to also have improved quality of life and functioning. A post hoc analysis of a clinical trial","volume":"13","author":"Peloso","year":"2016","journal-title":"Scandinavian Journal of Pain"},{"issue":"8","key":"10.1002\/14651858.CD012332.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Current Pain and Headache Reports"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0091|cit91","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"Suppl 3A","key":"10.1002\/14651858.CD012332.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0002-9343(86)90874-0","article-title":"Is there a metabolic basis for the fibrositis syndrome?","volume":"81","author":"Russell","year":"1986","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0093|cit93","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0094|cit94","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JPT Vist GE Glasziou P Guyatt GH Chapter 11: Presenting results and \u2018Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"5","key":"10.1002\/14651858.CD012332.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1089\/jwh.2008.1194","article-title":"Self-reported medication and herb\/supplement use by women with and without fibromyalgia","volume":"18","author":"Shaver","year":"2009","journal-title":"Journal of Womens Health"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00482-012-1174-0","article-title":"Etiology and pathophysiology of fibromyalgia syndrome","volume":"26","author":"Sommer","year":"2012","journal-title":"Schmerz"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00482-012-1172-2","article-title":"Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline","volume":"26","author":"Sommer","year":"2012","journal-title":"Schmerz"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0099|cit99","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0100|cit100","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2474-12-125","article-title":"Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response","volume":"12","author":"Straube","year":"2011","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"3","key":"10.1002\/14651858.CD012332.pub2-BIB0102|cit102","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pain.2009.03.013","article-title":"Non-steroidal anti-inflammatory drugs for neuropathic pain: how do we explain continued widespread use?","volume":"143","author":"Vo","year":"2009","journal-title":"Pain"},{"issue":"9859","key":"10.1002\/14651858.CD012332.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"issue":"9","key":"10.1002\/14651858.CD012332.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"e0138024","DOI":"10.1371\/journal.pone.0138024","article-title":"The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey","volume":"10","author":"Walitt","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1002\/14651858.CD012332.pub2-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012332.pub2-BIB0106|cit106","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD012332.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care and Research"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0108|cit108","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD012332.pub2-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/acr.21931","article-title":"Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population","volume":"645","author":"Wolfe","year":"2013","journal-title":"Arthritis Care and Research"},{"issue":"7","key":"10.1002\/14651858.CD012332.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/acr.22207","article-title":"What is fibromyalgia, how is it diagnosed and what does it really mean?","volume":"66","author":"Wolfe","year":"2014","journal-title":"Arthritis Care and Research"},{"issue":"4","key":"10.1002\/14651858.CD012332.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/j.1532-2149.2012.00234.x","article-title":"Longitudinal patterns of analgesic and central acting drug use and associated effectiveness in fibromyalgia","volume":"17","author":"Wolfe","year":"2014","journal-title":"European Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD012332.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0049-0172(81)90096-2","article-title":"Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls","volume":"11","author":"Yunus","year":"1981","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD012332.pub2-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","article-title":"Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness","volume":"37","author":"Yunus","year":"2008","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD012332.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1093\/brain\/awt053","article-title":"Small fibre pathology in patients with fibromyalgia syndrome","volume":"136","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Brain"},{"issue":"10","key":"10.1002\/14651858.CD012332.pub2-BIB0115|cit115","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010782","article-title":"Anticonvulsants for fibromyalgia","author":"\u00dc\u00e7eyler","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012332.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T15:02:18Z","timestamp":1636729338000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012332.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":115,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012332.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,27]]}}}